co-founder and chief medical officer of BioNTech. "We must not forget that cancer is also a global health threat, even worse than the current pandemic," she added.

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Pfizer/ BioNTech win U.K. nod for JN.1-adjusted COVID-19 ...

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

Update on Phase 3 Pfizer and BioNTech Combination Vaccine Trial ... match for the next season’s vaccine is difficult for global health experts as those strains are chosen more than six months ...

Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...

I am deeply troubled by the growing distrust of science in our society, just at the time when its insights are most needed.

German vaccine manufacturer BioNTech is to sponsor Bundesliga side Mainz, the club announced on Friday. Mainz said the ...

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

BioNTech’s pricing and coverage negotiations with governmental authorities, private health insurers and other third-party payors after BioNTech’s initial sales to national governments ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...